Southeast Asian Combat Sports Doping Control: Testing Costs Live in the Contract Appendix

On 14 March, a spreadsheet file on the hard drive of an assistant coach in Ho Chi Minh City was last modified at 23:41. The file carried no long title, only a short string of characters — the kind of name people give to something they do not want read. Inside were 26 rows, one per urine sample. The last three columns held the collection date, the laboratory code, and an empty cell. In 19 of the 26 rows, that empty cell contained the word "pending". Someone typed it, saved the file, and left it there for four months. No sample left the city during the gap between two events. The laboratory did not know the fighter's name. That is why I trust them.

Those four months were the entire rest period between one fight and the next. They are also the widest gap in professional combat sports across the region: the out-of-competition window.

In football or athletics, out-of-competition testing is the default — legislated, budgeted, and owned by someone. In combat sports, most Southeast Asian promoters test only on fight night, after the bout has ended, with two samples per main card bout. A fighter competing four times a year is tested four times, three months apart, while the detection window of most banned substances is far shorter. The gap is not one of technology. It is one of scheduling.

I began reconstructing this picture in 2026, as a student who happened to hold a leaked document from an anti-doping laboratory. That document taught me one thing: testing data is only worth something when you know who paid for it. Seven years later, I applied that rule to combat sports.

The unit price of a basic prohibited-substance test runs between 150 and 300 US dollars, before cold-chain shipping and coordination fees. A credible out-of-competition programme for a single fighter, with three to four random collections a year plus administration, costs around 1,500 dollars. A mid-tier regional card has 10 to 14 bouts — 20 to 28 fighters. Multiplied out, the figure is no longer small for a promoter earning a few hundred thousand dollars a night.

That is why testing costs rarely appear on the front page of a contract. A standard contract runs one page. A dirty contract comes with an appendix. In a template I cross-checked from a regional promoter, the testing clause sat in Appendix C, framed as an allocation of duties: the promoter covers testing on fight night, the fighter covers any testing arising outside it. That clause shifts the entire monitoring burden onto the worker, and drains the data pool in a fully legal way.

Based on my experience tracking bouts, I spent seven weeks cross-referencing 40 bouts across six regional events, including cards staged in Vietnam, Thailand and the Philippines, against published national anti-doping data. The finding was not in the number of positives. It was in the number of tests. Out-of-competition testing made up under 5 per cent of total collections in my sample. The rest were on fight night, when the body is at rest and most traces have already peaked.

Three samples from one young fighter I followed for 14 months showed what the first two refused to say. The first, taken after a May bout, was clean. The second, after a September bout, was clean. The third was not an official sample but a result from an independent test the fighter commissioned to defend himself in a contract dispute. Its markers diverged from the first two by a margin that three independent sports-medicine experts I contacted all described as unexplainable by training. I do not conclude the fighter used a banned substance. I conclude the current testing system cannot answer that question in either direction.

That is the point most public debate skips. When a promoter cannot test properly, the first casualty is not the cheat. The cheat benefits from the ambiguity. The first casualty is the clean fighter, who has no way to prove he is clean, and who — in a market where rumour travels faster than lab results — has his silence read as a signal.

There is an argument that holds up and that I once dismissed too quickly. Most combat sports promoters in the region are not large enterprises. They are small operators with thin revenue, and every dollar spent on testing is a dollar not spent on the purse pool. For a lightweight in a provincial town earning 500 dollars a fight, spending another 1,500 dollars a year to monitor him is not an easy sum. Apply international testing standards to the whole system overnight and many small events disappear — along with the income of fighters at the bottom.

The blind spot in that argument is that it treats testing as an add-on cost, when it is in fact a labour cost. A fighter suspended for two years over an opaque test result loses far more than 1,500 dollars. A fighter accused online with no evidence to rebut loses sponsors before he loses a bout. Seen from the worker's side, out-of-competition testing is not a line item to polish a promoter's image. It is the condition for surviving in a trade where reputation is the only asset you can carry out the door.

A urine sample carries no fighter's name, and that is its strength. The problem in Southeast Asian combat sports is that nobody is accountable for collecting enough samples to make an answer mean anything. If this industry wants to talk about transparency, the first thing it should publish is out-of-competition test counts, by promoter, by year. There is no need to wait for the first positive. The stadium is spotless. The locker room is not. And the locker room is where contracts get signed.